A61P 33 - Antiparasitic agents

Patents for A61P 33 - Antiparasitic agents (21,787)
12/2004
12/07/2004	US6828416 Recombinant multivalent malarial vaccine against Plasmodium falciparum
12/07/2004	CA2352332C Hygromycin a derivatives
12/07/2004	CA2105251C Novel processes for the production of 13-ether derivatives of milbemycins, and novel intermediates therefor
12/02/2004	WO2004103985A2 Derivatives of fusarochromanone as therapeutic agents
12/02/2004	WO2004103363A1 Use of poly-amminopyrrolecarboxamides alone or in combination with a cyclodextrin in the prophylaxis and treatment of animal parasitosis
12/02/2004	WO2004026815A3 Phenol derivatives and their use as rotamase inhibitors
12/02/2004	WO2003063767A3 Rsv proteins, antibodies, compositions, methods and uses
12/02/2004	US20040242913 A aromatic cyanoamide compound; pesticides; veterinary medicine
12/02/2004	US20040242868 Controlling cytokines; antiinflammatory agents; rheumatic disoreders; skin disorders; respiratory system disorders; Alzheimer's disease; Parkinson's disease; Huntington"s disease ; amyotrophic lateral sclerosis
12/02/2004	US20040242664 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
12/02/2004	US20040242614 Pharmaceutically active compounds and methods of use thereof
12/02/2004	US20040242488 Peptides having same amino acid sequence and same anti-microbial activity as those of Phylloseptins which are isolated from the skin of Phyllomedusa hypochondrialis; the 19-residue anti-microbial peptides are cationic and based on their primary structure, all peptides can fitted to an amphiphilic a-helix
12/02/2004	US20040241248 Crosslinking the carboxylic acid groups in a glycosaiminoglycan with a primary amine in a lipid to form particles that can be used to encapsulate various drugs, especially chemotherapeutic agents
12/02/2004	US20040241204 Sustained release pharmaceutical composition
12/02/2004	US20040241194 A synergistic mixture of a eucalyptus extract, a fenugreek extract, and a boldo extract; curative or preventive treatment of ruminant, poultry, rabbit and pig coccidiosis; more efficient than when using eucalyptus oil on its own
12/01/2004	EP1481006A2 Universal antimicrobial treatment
12/01/2004	EP1480621A1 Ph-sensitive cationic lipids, and liposomes and nanocapsules containing the same
12/01/2004	EP1480598A2 Manipulation of cytokine levels using cd83 gene products
12/01/2004	EP1261355B1 Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response
12/01/2004	CN1551782A Chimeric flavivirus vectors
12/01/2004	CN1177823C Pesticides
11/2004
11/30/2004	US6825231 Substituted norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and a medicament comprising them
11/30/2004	US6825230 Spiro and dispiro 1,2,4-trixolane antimalarials
11/30/2004	US6825204 N-substituted 3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
11/30/2004	CA2298245C Matrix controlled release device
11/30/2004	CA2089309C Novel pharmaceutical uses of bilobalide and derivatives thereof and pharmaceutical compositions adapted for such use
11/25/2004	WO2004100861A2 Pharmaceutical composition comprising lectin
11/25/2004	WO2004080420A3 A method for the prevention of malaria infection of humans by hepatocyte growth factor antagonists
11/25/2004	US20040236137 A carbonyloxycyano compound; pesticides; veterinary medicine
11/25/2004	US20040235962 Conformationally restricted polyamine analogs as disease therapies
11/25/2004	US20040235868 Purine derivatives having, in particular, anti-proliferative properties and their biological uses
11/25/2004	US20040235816 Administering compounds such as 1-benzhydryl-3-[(methylsulfonyl)(phenyl)methylene]azetidine for therapy of schizophrenia, Parkinson's disease, and Alzeimer's disease
11/25/2004	US20040235759 Increasing acute or chronic injection-site toleration in mammals by administering single dose descladinose azalide derivative mixture
11/25/2004	US20040235097 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
11/25/2004	US20040234572 Preparation of sustained release pharmaceutical composition
11/25/2004	US20040234533 Antigenic compositions
11/25/2004	US20040234522 therapy, diagnosis of immunology diseases; response to antigenic stimulants; cell differentiation of lymphocytes
11/24/2004	EP1479773A1 Mite galectin
11/24/2004	EP1479697A1 Tick chitinase
11/24/2004	EP1479394A1 The use of epidermal growth factor (EGF) for increasing weight gain in an animal
11/24/2004	EP1478762A2 Nucleic acid-associated proteins
11/24/2004	EP1478393A2 Anti-pathogen treatements
11/24/2004	EP1478372A1 Long acting parasiticidal composition containing a salicylanilide compound, a polymeric species and at least one other anti-parasitic compound
11/24/2004	EP1478359A1 Piperidin-4-yl urea derivatives and related compounds as chemokine receptor inhibitors for the treatment of inflammatory diseases
11/24/2004	EP1478358A1 Aryl ureas with angiogenesis inhibiting activity
11/24/2004	EP1478347A1 Dry granulated formulations of azithromycin
11/24/2004	EP1183231B1 Cytofectin dimers and methods of use thereof
11/24/2004	CN1549717A Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity, process for producing them and pharmaceutical compositions containing them
11/24/2004	CN1548436A Novel 2-alkyl substituted imidazole compounds
11/24/2004	CN1548052A Application of aescin and its derivative in preparing medicine for treating acute pulmonary inflammation and hydrops
11/24/2004	CN1548043A Secnidazole injection and its prepn process
11/24/2004	CN1176684C Medicine 'Jiwenning' for treating chicken pest and its preparing process
11/23/2004	US6821986 Drugs such as (2s)-2-amino-n-(4-anilinophenyl)-5-((imino(2-oxido-2 -oxohydrazino)methyl)amino) pentanamide, used as nitric oxide synthase inhibitors, free radical scavangers or as antioxidants
11/23/2004	US6821510 Administration of a reactive oxygen species (ros) inhibitor or scavenger (a histmine or its salt, ester, prodrug and agonist) and at least one monocyte maturation promoting agent (a cytokine)
11/23/2004	CA2332087C Aryl substituted azabenzimidazoles and their use in the treatment of hiv and aids related diseases
11/18/2004	WO2004066725A3 Avermectin- and avermectin monosaccharide derivatives substituted in the 4”- or 4’-position having pesticidal properties
11/18/2004	WO2003038043A3 Combinations of dr5 antibody and other therapeutic agents
11/18/2004	US20040229897 Aid in cytokine biosynthesis
11/18/2004	US20040229882 dipeptide or tripeptide MC-1R and MC-4R agonists
11/18/2004	US20040229835 Immunostimulatory nucleic acid molecules
11/18/2004	US20040229831 Compositions and methods for non-parenteral delivery of oligonucleotides
11/17/2004	EP1477181A1 Method of stimulating growth and resistance to diseases of aquatic organisms
11/17/2004	EP1476752A1 Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome
11/17/2004	EP1476540A1 Methods for producing gama delta t cells
11/17/2004	EP1476539A2 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
11/17/2004	EP1476456A2 Compositions and methods for surrogate antibody modulation of an immune response and transport
11/17/2004	EP1476160A1 Pharmaceutical combination of artesunate and mefloquine for therapy of malaria
11/17/2004	EP1476159A2 Compositions and formulations of 9- nitrocamptothecin polymorphs and methods of use thereof
11/17/2004	EP1476157A1 Nicotinamide derivatives useful as pde4 inhibitors
11/17/2004	EP1476018A1 Immunostimulant compositions comprising aminoalkyl glucosaminide phosphates and saponins
11/17/2004	CN1546109A Protective agent preparing by manioca seed for preventing japanese blood fluke infection
11/17/2004	CN1546020A Vaginal effervescence tablet of secnidazole and its preparation
11/16/2004	US6818670 Active ingredient combination having insecticidal and acaricidal characteristics
11/11/2004	WO2004035021A3 Buccal polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
11/11/2004	US20040224911 Transporters and ion channels
11/11/2004	US20040224910 Recombinant nematode nicotinic receptor and uses
11/11/2004	US20040224904 Carbohydrate scaffold, carrying two side chains, which form a macrocyclic ring that may be unsaturated and contains ether, amide, ester and/or carbamate groups; for therapy of bacterial, fungal, viral or protozoal infections or tumors
11/11/2004	US20040224356 Novel human enzymes of the metalloprotease family
11/11/2004	US20040224350 Dirofilaria non-collagenous protein for use in developing vaccine for prevention and treatment of nematode infection; veterinary medicine
11/11/2004	US20040224314 G-protein coupled receptors
11/11/2004	US20040223961 Enzyme treatment
11/10/2004	EP1475374A1 Thiadiazole compounds and use thereof
11/10/2004	EP1474432A1 Immunostimulatory, covalently lipidated oligonucleotides
11/10/2004	EP1474413A2 Novel decalactones from associated fungi of marine sponges and their synthetic derivatives as medicaments
11/10/2004	EP1474396A2 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
11/10/2004	EP1474395A1 Nicotinamide derivates useful as p38 inhibitors
11/10/2004	EP1474155A1 Method of treatment of gastrointestinal disease and polymeric composition for use therein
11/10/2004	EP1261605B1 Benzoxazole derivatives as tnf and pde iv inhibitors
11/10/2004	EP1237562B1 Process for preparing mikania extracts containing mikanolide and dihydromikanolide and use in the treatment of proliferative disorders
11/10/2004	CN1545508A 1,2,4-trioxolane antimalarials
11/10/2004	CN1545500A Carbonyloxy-cyanomethyl compounds as antiparasitic agents
11/10/2004	CN1544629A Method for preparing recombinant goose interleukin-2 protein and its application
11/10/2004	CN1544628A Trichina TS88 gene, their protein products and uses
11/10/2004	CN1544086A Application of apolipoprotein A-I in the preparing process for medicine capable of resisting endotoxin and inhibiting cytokine release
11/10/2004	CN1543941A Combined sustained release agent and preparation thereof for preventing and treating livestock helminth, acarid and ectosarc disease
11/10/2004	CN1174761C Medicine composition for treating echinococcosis and its preparing process
11/04/2004	WO2004075912B1 Use of pgrp, lrrp and ctl proteins to trigger an anti-plasmodium immune response in anopheles species
11/04/2004	WO2002092013A3 Methods for treating liver disease and liver damage with growth hormone and foxm1b
11/04/2004	WO1999029693A8 Imidazonaphthyridines and their use in inducing cytokine biosynthesis
11/04/2004	US20040220148 5-Membered ring heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists

1 ... 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 ... 218